Goehring & Rozencwajg Associates LLC Reduces Stake in Cameco Co. (NYSE:CCJ)

Goehring & Rozencwajg Associates LLC reduced its position in Cameco Co. (NYSE:CCJFree Report) (TSE:CCO) by 10.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 658,629 shares of the basic materials company’s stock after selling 80,874 shares during the period. Cameco makes up about 7.0% of Goehring & Rozencwajg Associates LLC’s investment portfolio, making the stock its 2nd largest position. Goehring & Rozencwajg Associates LLC’s holdings in Cameco were worth $34,203,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CCJ. Sanctuary Advisors LLC purchased a new stake in shares of Cameco during the 2nd quarter valued at about $349,000. Park Avenue Securities LLC lifted its position in Cameco by 18.9% during the third quarter. Park Avenue Securities LLC now owns 4,975 shares of the basic materials company’s stock valued at $238,000 after purchasing an additional 790 shares during the period. Dynamic Advisor Solutions LLC boosted its holdings in Cameco by 7.0% in the third quarter. Dynamic Advisor Solutions LLC now owns 9,609 shares of the basic materials company’s stock worth $459,000 after purchasing an additional 632 shares during the last quarter. Private Advisory Group LLC bought a new stake in Cameco in the 3rd quarter worth approximately $5,889,000. Finally, Covea Finance raised its stake in Cameco by 4.2% during the 3rd quarter. Covea Finance now owns 1,153,551 shares of the basic materials company’s stock valued at $55,119,000 after buying an additional 46,500 shares during the last quarter. 70.21% of the stock is owned by institutional investors.

Cameco Price Performance

NYSE CCJ opened at $49.97 on Friday. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.88 and a quick ratio of 1.26. Cameco Co. has a 1-year low of $35.43 and a 1-year high of $62.55. The stock has a market capitalization of $21.75 billion, a price-to-earnings ratio of 263.02 and a beta of 0.94. The business’s fifty day moving average price is $53.07 and its 200-day moving average price is $49.35.

Cameco (NYSE:CCJGet Free Report) (TSE:CCO) last announced its earnings results on Thursday, November 7th. The basic materials company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.40). Cameco had a return on equity of 3.33% and a net margin of 4.15%. The firm had revenue of $721.00 million during the quarter, compared to analysts’ expectations of $646.83 million. During the same period in the previous year, the business posted $0.24 earnings per share. The company’s revenue for the quarter was up 25.4% on a year-over-year basis. On average, equities analysts predict that Cameco Co. will post 0.47 earnings per share for the current year.

Cameco Company Profile

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

See Also

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Co. (NYSE:CCJFree Report) (TSE:CCO).

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.